Sanofi SA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Sanofi SA
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
/ 
Sanofi SA (SAN) is a French multinational pharmaceutical company headquartered in Paris, France. Originally established in 1973, Sanofi has grown through a series of mergers and acquisitions to become one of the world's leading healthcare companies.
The company's activities focus on prescription medicines and vaccines, and it now holds a minority stake in consumer healthcare following the 2025 separation of Opella. Sanofi has a strong presence in specialty care areas such as immunology, oncology, neurology, and rare diseases, as well as in diabetes and cardiovascular treatments. Through its Vaccines division, it is also a global leader in vaccines.
Sanofi operates research and production facilities worldwide, with a significant footprint in Europe, North America, and emerging markets. The group is investing in biotechnology, mRNA platforms, and other innovative therapies to address unmet medical needs and support global health initiatives.
Sanofi SA is listed on the Euronext Paris stock exchange.
Saxo provides this content for general information only. It is not intended as personal advice, an offer, or a recommendation. Saxo does not guarantee accuracy or completeness and accepts no liability for losses. Consider obtaining independent advice before any investment decision.
Frequently asked questions
To buy Sanofi SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sanofi SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sanofi SA is SAN:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sanofi SA has its primary listing on Euronext Paris. You can trade Sanofi SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sanofi SA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Sanofi SA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Sanofi SA.